| Senior Scientific
Staff |
||||
 Russell
L. Wolz, Ph.D. Dr. Wolz joined the Company in August, 1996, as Senior Research Scientist. Wolz heads the Company's biochemistry research services. Until 1996, Wolz was Assistant Professor at Indiana University of Pennsylvania, and was previously an Assistant Professor in the Department of Biochemistry and Molecular Biology at the Penn State University College of Medicine, Hershey, PA. Dr. Wolz received a Bachelor's degree in Chemistry from Colorado State University, and the Doctoral degree from Northwestern University, in Biochemistry. Wolz is the co-author of more than 15 peer reviewed journal articles and book chapters in the general areas of his research expertise, protein structure and function. Wolz is credited with co-discovery of the zinc binding motif common to all zinc-metallo proteinases. Wolz is the Principal Investigator on Phase I and Phase II Small Business Innovative Research Awards issued to the Company from the NIH and USDA, respectively. |
||||
 Natesa
Muthukumaraswamy, Ph.D. Dr."Swamy" joined the Company in January, 1997, as Senior Scientist. Prior to joining the Company Swamy was on the faculty of Virginia Commonwealth University, first in the Department of Pharmacology & Toxicology (1977-1992) and then in the Department of Biomedical Engineering (1992-1997). Swamy is an integral member of the peptide synthesis group, and is expert in all phases of solid-phase and solution-phase chemical synthesis of peptides and peptide analogs. Swamy received the Bachelor's and Masters degrees in Chemistry from Madras University, Madras, India, and the Doctoral degree in Organic Chemistry from the same institution. He is the co-author of more than 30 peer reviewed journal articles and book chapters. |
||||
 Darin
R. Kent, Ph.D. Dr. Kent joined the Company in October, 1997, as Research Scientist, and heads the Company's bioorganic research services. Until 1997, Kent was employed at Parke Davis Pharmaceutical Research Center, a Division of the Warner Lambert Company. Dr. Kent received a Bachelor's degree in Biochemistry (Cum Laude) from the California State University, San Francisco, and the Doctoral degree from the University of California at San Diego, in Organic Chemistry. Kent is the co- author of 10 peer reviewed journal articles in the general areas of his research expertise, asymmetric synthesis and peptidomimetics. |
||||
 Douglas R. Oliveri, PhD, FACMG. Dr. Oliveri joined the Company in February, 1999, as Director of Human Genetics and Genetic Analysis. From 1995-1999, he served as Director of the DNA Laboratory at Applied Genetics in Austin, TX. From 1992-1995, he served as assistant professor of pathology and human genetics at the University of Pittsburgh and as a full member of the Pittsburgh Cancer Institute. Dr. Oliveri holds certifications in Clinical Molecular Genetics and Clinical Biochemical Genetics by the American Board of Medical Genetics. He received his Bachelor's degree in Biology from St. Louis University, Doctoral degree in Genetics from the University of California, Davis, and Post Graduate Human Genetics Training from the University of Chicago. |
||||
 Julie R.
Secor McVoy, M.S. Ms. McVoy joined the Company in April, 1994 and has since been promoted to Senior Laboratory Specialist. Ms. McVoy is considered an expert in all aspects of immunochemistry and immunoassay and has taken charge of the Company's efforts in assay development. Ms. McVoy received her Bachelor's degree in Biology from the College of William and Mary, and her Master of Science degree in Human Genetics from Virginia Commonwealth University, the Medical College of Virginia. Ms. McVoy is the recipient of many awards for scientific excellence and helped develop assay methods for biotinidase deficiency, including an assay that is currently used in neonatal screening programs throughout the world. Ms. McVoy is the co-author of numerous peer reviewed journal articles in the general areas of her research expertise, human biochemical genetics. |
||||
 Richard I. Jaffe, Ph.D., MT(ASCP) Dr. Jaffe is CBI's Director of Microbiology and Special Government Projects. Formerly, Jaffe was a commissioned officer in the United States Air Force and Chief of Molecular Biology for the Clinical Investigation Facility at Travis AFB, CA. Dr. Jaffe received the BS degree in Microbiology from the University of Maryland at College Park, the MS degree in Human Genetics from George Washington University, and the Ph.D. in Microbiology from Virginia Commonwealth University, the Medical College of Virginia. Jaffe is a board registered medical technologist and the recipient of many awards for excellence in science and the military. He also is the co-author of numerous peer reviewed journal articles in the general areas of his research expertise, microbiology and molecular biology. Dr. Jaffe is currently a captain in the United States Air Force Reserves. |
||||
 Steve J. Carlisle,
Ph.D.Dr. Carlisle joined the Company in January 2000 as Scientist, and is a senior member in the Molecular Biology group. Prior to working for CBI, Dr. Carlisle was a postdoctoral fellow in the department of Microbiology and Toxicology at the Medical College of Virginia at Virginia Commonwealth University where he studied the effects of Cannabinoids on the mammalian immune system. Dr. Carlisle received the Bachelor of Science degree in Biology from the College of William and Mary, and the Doctoral degree in Molecular Physiology and Biological Physics from the University of Virginia. Dr. Carlisle is the co-author of several peer reviewed articles in the fields of Immunology and Receptor Biology. |
||||
|
